Skip to main content

Cycurion, Inc.

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

CYCU$2.470.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

September 30, 2025December 31, 2024
Assets:
Cash and cash equivalents$3,652,074$38,742
Restricted cash-2,048
Accounts receivable, net3,097,05410,353,708
Other receivables230,175434,391
Prepaid expenses and other current assets57,13799,463
Total current assets7,036,44010,928,352
Deposit for acquisition target-2,000,000
Property and equipment, net-20,321
Software development costs4,419,9814,151,981
Intangible assets, net-25,000
Security deposits10,35110,351
Goodwill20,842,5086,592,304
Investments held in trust account-1,834,540
Total non-current assets25,272,84014,634,497
Total Assets$32,309,280$25,562,849
Liabilities, Mezzanine and Stockholders’ Equity:
Bank loan-revolving credit line$3,231,067$3,249,067
Bank loan - current portion276,012774,095
Loans payable - current portion885,240408,516
Factoring liability1,681,981-
Subordinated convertible promissory notes-3,333,335
Promissory notes2,658,6632,486,989
Loans payable - related parties123,650148,088
Accounts payable2,508,7713,578,374
Due to related party18,000-
Accrued liabilities4,053,3263,601,242
Excise tax payable1,167,1731,157,161
Total current liabilities16,603,88318,736,867
Loans payable - non-current portion295,296146,798
Series A Convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding, respectively)-1,294,117
Total non-current liabilities295,2961,440,915
Total liabilities16,899,17920,177,782
Commitments and contingencies (Note 21)
Mezzanine Equity:
Common stock subject to possible redemption, $0.0001 par value, 0 and 5,796 shares at redemption value of approximately $11.03 per share, respectively-1,917,309
Stockholders’ Equity:
Preferred stock ($0.0001 par value, 20,000,000 shares authorized)
Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 0 and 0 issued and outstanding, respectively)--
Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 1 and 3,000 issued and outstanding, respectively)--
Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 4,851 issued and outstanding)--
Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 0 issued and outstanding, respectively)15-
Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 0 issued and outstanding, respectively)--
Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively)--
Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 3,318 and 0 issued and outstanding, respectively)
Common stock ($0.0001 par value, 300,000,000 shares authorized, 2,662,489 and 353,087 shares issued and outstanding, respectively)26635
Additional paid in capital40,866,3286,671,084
Accumulated deficit(21,773,931)(3,203,361)
Total stockholders’ equity attributable to Cycurion19,092,6783,467,758
Deficit attributable to noncontrolling interests(3,682,577)-
Total stockholders’ equity15,410,1013,467,758
Total liabilities and stockholders’ equity$32,309,280$25,562,849
See accompanying notes to unaudited consolidated financial statements.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.